Paradigm’s Post

View organization page for Paradigm, graphic

4,585 followers

Paradigm is building a new model for #clinicaltrials, from the ground up, using technology to scale access. Recently, we worked with OpenAI to evaluate GPT-4 to reduce the administrative burden of screening patients for clinical trials. Our team achieved amazing results, exceeding accuracy of industry best practice while dramatically decreasing the time to read, extract, and interpret medical record data. By incorporating LLMs into Paradigm’s platform, we can screen every patient faster, more accurately, and at a dramatically lower cost, helping create equitable access for any patient, anywhere. We are excited that OpenAI shared our results here: https://lnkd.in/eE5MYUzw

  • No alternative text description for this image

🔥

Like
Reply
Enzo P.

CCO | Behavioral Scientist | Entrepreneur

6mo

Congrats, and great use case for GPT 4!

Like
Reply
Mary Martin, MS, RN

Business Development I Partnerships & B2B Strategies I Go to Market Strategy | #cancerresarch # oncology #realworlddata #digitalhealth

6mo

exciting results- Jonathan Hirsch

See more comments

To view or add a comment, sign in

Explore topics